Symbol="BTAI"
AssetType="Common Stock"
Name="BioXcel Therapeutics Inc"
Description="BioXcel Therapeutics, Inc., a clinical-phase biopharmaceutical company, focuses on the development of artificial intelligence-based drugs in the fields of neuroscience and immuno-oncology in the United States. The company is headquartered in New Haven, Connecticut."
CIK="1720893"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="555 LONG WHARF DRIVE, NEW HAVEN, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="300344000"
EBITDA="-179032992"
PERatio="None"
PEGRatio="None"
BookValue="1.821"
DividendPerShare="0"
DividendYield="0"
EPS="-6"
RevenuePerShareTTM="0.021"
ProfitMargin="0"
OperatingMarginTTM="-308.71"
ReturnOnAssetsTTM="-0.573"
ReturnOnEquityTTM="-1.515"
RevenueTTM="581000"
GrossProfitTTM="355000"
DilutedEPSTTM="-6"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="45.09"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4131.89"
PriceToBookRatio="3.966"
EVToRevenue="2657.94"
EVToEBITDA="-2.748"
Beta="0.84"
num_52WeekHigh="34.12"
num_52WeekLow="5.88"
num_50DayMovingAverage="19.37"
num_200DayMovingAverage="20.18"
SharesOutstanding="29159600"
DividendDate="None"
ExDividendDate="None"
symbol="BTAI"
open="11.18"
high="11.36"
low="10.26"
price="10.30"
volume="1694237.00"
latest_trading_day="2023-07-14"
previous_close="11.39"
change="-1.09"
change_percent="-9.5698%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="64"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="36"
Volume_recent_avg="1764745"
Change_recent_avg="-0.11"
Delta_recent_avg="1.63"
Variance_recent_avg="0.81"
Change_ratio_recent_avg="-0.64"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="36"
Aroon_momentum_negative="64"
image_negative_thumbnail_id_1="110"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0066.jpeg"
image_negative_thumbnail_id_2="145"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0031.jpeg"
image_neutral_thumbnail_id_1="526"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_neutral_thumbnail_id_2="549"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_positive_thumbnail_id_1="969"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0131.jpeg"
image_positive_thumbnail_id_2="635"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0073.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1180"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
